Filing Details
- Accession Number:
- 0001628280-19-010686
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-13 16:33:57
- Reporting Period:
- 2019-08-09
- Accepted Time:
- 2019-08-13 16:33:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576280 | Guardant Health Inc. | GH | Services-Medical Laboratories (8071) | 454139254 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721003 | B. Richard Lanman | 505 Penobscot Drive Redwood City CA 94063 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-09 | 2,307 | $4.18 | 141,632 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-08-09 | 3,458 | $8.80 | 145,090 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-09 | 11,399 | $103.79 | 133,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-09 | 16,060 | $104.80 | 117,631 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-09 | 25,520 | $105.69 | 92,111 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-09 | 9,596 | $106.47 | 82,515 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-09 | 500 | $107.18 | 82,015 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2019-08-09 | 2,307 | $0.00 | 2,307 | $4.18 |
| Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2019-08-09 | 3,458 | $0.00 | 3,458 | $8.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,371 | 2027-05-30 | No | 4 | M | Direct | |
| 42,655 | 2028-08-21 | No | 4 | M | Direct |
Footnotes
- These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of one or more stock options at an exercise price of $4.18 or $8.80 per share.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.10 to $104.08. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $104.11 to $105.10. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.11 to $106.10. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.11 to $107.02. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 1, 2017.
- The expiration date of May 31, 2027 reported in the Reporting Person's prior Form 4 filings was in error.
- The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
- The expiration date of August 22, 2028 reported in the Reporting Person's prior Form 4 filings was in error.
Billionaire Hedge Funds
